COVID-19 surveillance (as of 16 May 2022)
2,172,342
coronavirus genomes sequenced by the Sanger Institute
300+
Sanger staff are part of the 7-days-per-week operation
10,838,272
coronavirus genomes sequenced around the globe (GISAID)
How COVID-19 surveillance works
Sanger Seminar: Comprehensive genomic surveillance of SARS-CoV-2 in the UK
Seminar: How we read SARS-CoV-2 genomes, and how these data are used by the COG-UK Consortium to track the spread of the virus, and identify new variants; including B.1.1.7.
Q&A session with Dr Jeff Barrett, Director the Wellcome Sanger Institute COVID-19 Genomics Initiative.
Human Cell Atlas COVID-19 research
As part of our work in the Human Cell Atlas initiative, our research teams explore how the SARS-CoV-2 virus enters people’s cells and cause symptoms.
To find out more, please visit: https://www.humancellatlas.org/covid-19/
